Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen O'Neill

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|October 27, 2011
Effectiveness of interventions designed to modify and maintain perceptual abilities in people with Alzheimer's disease and related dementiasLori Letts, Jacqueline Minezes, Mary Edwards, et al.
Biochemistry|October 27, 2011
Branched intermediate formation is the slowest step in the protein splicing reaction of the Ala1 KlbA intein from Methanococcus jannaschiiLana Saleh, Maurice W Southworth, Nancy Considine, et al.
Diabetes|November 25, 2004
Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and EuropeBernard Zinman, Steven E Kahn, Steven M Haffner, et al.
The American Journal of Managed Care|April 21, 2005
Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) studyWilliam H Herman, Riad G Dirani, Ruslan Horblyuk, et al.
Diabetes, Obesity & Metabolism|December 22, 2005
Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) studyJ Rosenstock, B J Goldstein, A I Vinik, et al.
The New England Journal of Medicine|December 6, 2006
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapySteven E Kahn, Steven M Haffner, Mark A Heise, et al.
Diabetes|July 29, 2006
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetesSteven E Kahn, Bernard Zinman, Steven M Haffner, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|October 27, 2011
Effectiveness of interventions designed to modify and maintain perceptual abilities in people with Alzheimer's disease and related dementiasLori Letts, Jacqueline Minezes, Mary Edwards, et al.
Biochemistry|October 27, 2011
Branched intermediate formation is the slowest step in the protein splicing reaction of the Ala1 KlbA intein from Methanococcus jannaschiiLana Saleh, Maurice W Southworth, Nancy Considine, et al.
Diabetes|November 25, 2004
Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and EuropeBernard Zinman, Steven E Kahn, Steven M Haffner, et al.
The American Journal of Managed Care|April 21, 2005
Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) studyWilliam H Herman, Riad G Dirani, Ruslan Horblyuk, et al.
Diabetes, Obesity & Metabolism|December 22, 2005
Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) studyJ Rosenstock, B J Goldstein, A I Vinik, et al.
The New England Journal of Medicine|December 6, 2006
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapySteven E Kahn, Steven M Haffner, Mark A Heise, et al.
Diabetes|July 29, 2006
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetesSteven E Kahn, Bernard Zinman, Steven M Haffner, et al.
Pageof 2